“…Regardless of the reason, there is mounting evidence that CRT alone is a viable option for the treatment of advanced NPC. However, it remains to be seen whether adjuvant therapy would be more appropriate for certain patient subgroups, as suggested by results from other studies [47]. Additional information is anticipated from a recently completed multicentre randomised trial (NCT00677118) comparing CRT-A and CRT.…”